Magnetic Nanoparticles in the Mice: Jung-Taek KWON, et al. Laboratory of Toxicology, College of Veterinary Medicine, Seoul National University, Korea-Reducing the particle size of materials is an efficient and reliable tool for improving the bioavailability of a gene or drug delivery system. In fact, nanotechnology helps in overcoming the limitations of size and can change the outlook of the world regarding science. However, a potential harmful effect of nanomaterial on workers manufacturing nanoparticles is expected in the workplace and the lack of information regarding body distribution of inhaled nanoparticles may pose serious problem. In this study, we addressed this question by studying the body distribution of inhaled nanoparticles in mice using approximately 50-nm fluorescent magnetic nanoparticles (FMNPs) as a model of nanoparticles through nose-only exposure chamber system developed by our group. Scanning mobility particle sizer (SMPS) analysis revealed that the mice were exposed to FMNPs with a total particle number of 4.89 × 10 5 ± 2.37 × 10 4 /cm 3 (low concentration) and 9.34 × 10 5 ± 5.11 × 10 4 /cm 3 (high concentration) for 4 wk (4 h/d, 5 d/wk). The body distribution of FMNPs was examined by magnetic resonance imaging (MRI) and Confocal Laser Scanning Microscope (CLSM) analysis. FMNPs were distributed in various organs, including the liver, testis, spleen, lung and brain. T2-weighted spin-echo MR images showed that FMNPs could penetrate the blood-brain-barrier (BBB). Application of nanotechnologies should not produce adverse effects on human health and the
Rapid development in nanotechnology will result in several changes in areas such as nanoscale visualization, insight into living systems, revolutionary biotechnology, synthesis of new drugs for targeted delivery and regenerative medicine, and will offer many other benefits 1) . Reducing the particle size of materials is an efficient and reliable tool for improving the bioavailability of a gene or drug delivery system. In fact, nanotechnology helps to overcome the limitations of size and can change the outlook of the world regarding science 2) . However, a potential harmful effect of nanomaterials on workers manufacturing nanoparticles is expected in the workplace and the lack of information regarding body distribution of inhaled nanoparticles may pose a serious problem. Therefore, it is necessary that specialists and researchers in toxicology, chemistry and other fields are aware of the importance of analyzing the positive aspects of nanomaterials while avoiding their potential toxic effects 3) . In a previous study, we reported that fluorescent magnetic nanoparticles (FMNPs) did not cause any significant toxicity and penetrated the blood-brain-barrier (BBB) in mice treated by i.p. administration 4) . However, for the bioapplication of FMNPs, data regarding the toxicity depending upon exposure routes should be accumulated. In fact, dominant routes of exposure to
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workers can be representative organs such as the lung (inhalation) which contains barriers to penetration by small particles. Regardless of the presence of such a defense mechanism, nano-sized materials may present problems for workers because the defense mechanism may not respond properly to nano-sized materials. However, studies have not investigated the inhalation toxicity of nanoparticles yet.
In this study, we addressed this issue by studying the body distribution of inhaled nanoparticles in mice using approximately 50-nm FMNPs as a model of nanoparticles through a nose-only exposure chamber system developed by our group. Here, we report that inhaled FMNPs were distributed diversely in organs including the brain and testis. Our results support the hypothesis that extensive toxicity evaluation is needed before the practical application of anthropogenic nanomaterials and suggest that careful regulation of nanoparticles' application may be necessary to maintain a high quality of life as well as to facilitate the development of nanotechnology.
Materials and Methods

Fluorescent magnetic nanoparticles (FMNPs)
FMNPs were synthesized by the co-precipitation method in hot basic NaOH solution as described in a previous study 5) . Briefly, a ferrite aqueous solution was added to polyvinylpyrrolidone (PVP) solution, and the mixture was stirred for 1 d at room temperature. RITCmodified triethoxysilane was prepared from aminopropyltriethoxysilane (APS) and RITC under nitrogen using a standard Schlenk line technique. A mixed solution of tetraethoxysilane (TEOS) and RITC-modified triethoxysilane (TEOS/RITC-silane molar ratio=0.3/0.04) was injected into the ethanol solution of PVP-stabilized ferrite. The PVP-stabilized FMNPs were separated by the addition of aqueous acetone followed by centrifugation at 4,000 rpm for 10 min. The supernatant was removed and the precipitated particles were redispersed in ethanol. The size and shape of the FMNPs were characterized by a transmission electron microscope (TEM). The prepared core-shell nanoparticles were homogeneously dispersed in distilled water.
Animals and experiment design
Specific-pathogen-free male and female Slc: ICR mice (5 wk old) purchased from SLC Inc. (Hamamatusu, Japan) were maintained in our laboratory animal facility (23 ± 2°C, 50 ± 20% relative humidity, 12-h light/dark cycle). The mice were acclimatized for at least 1 wk prior to the beginning of the study. All animal experiments were performed according to the guideline for the care and use of laboratory animal of Seoul National University. We randomized mice into 3 groups (10 male and female mice per group): control, low and high FMNPs exposure groups. In this study, the total particle numbers in the nose-only exposure chamber system were maintained at 4.89 × 10 5 #/cm 3 for low concentration and 9.34 × 10 5 #/cm 3 for high concentration. The animals were exposed to FMNPs for 4 wk (4 h/d, 5 d/wk) in the nose-only exposure system. Controls were exposed to air filtered by a high efficiency particulate air (HEPA) filter. The body distribution of FMNPs was evaluated by magnetic resonance imaging (MRI) and Confocal Laser Scanning Microscope (CLSM).
FMNPs generation and exposure
The nose-only exposure chamber used in our study consists of a cylindrical acrylic cylinder and 20 small tubes (Fig. 1A) . A serial aerosol device was constructed on the basis of an 84 × 540 mm acrylic cylinder (main chamber). Conical acrylic tubes were connected to the main chamber and the mice were placed in the tubes from the backside. FMNPs were suspended in distilled water. The atomizer (Model 9302, TSI, MN, USA) generated the nanoparticles and these particles were forced to pass through a heating tube where any remaining distilled water was allowed to evaporate completely. The heating tube temperature was maintained at 120-130°C 6) . The generated aerosols were entered into the dilution chamber where the aerosols were mixed with filtered air using HEPA cartridge-type filter (Model 12144, Pall, NY, USA) before passing into the nose-only exposure chamber. Particle number and size distribution were measured using a scanning mobility particle sizer (SMPS, Grimm Aerosol Technik, Germany) 6, 7) . The SMPS, which consists of a differential mobility analyzer (DMA) and a condensation particle counter (CPC), is an instrument for measuring the size distribution of particles in the range from 5 to 1,000 nm. The flow rate for the chamber was set at 12 l per minute. When the airflow became stabilized, the nanoparticle number and size in the nose-only exposure chamber were measured at the center of the chamber. In addition, to further validate the real size of FMNPs, the FMNPs were sampled by a glass fiber filter (Model 66209, Pall) during exposure period and analyzed by scanning electron microscope (SEM).
Fluorescent image analysis
For fluorescent image analysis, brain, liver, nasal cavity, lungs, kidneys, heart, spleen, testes (male), and ovary (female) were removed and the organs were immersion-fixed in 10% neutral buffered formalin. After routine tissue processing, the tissues were embedded in low temperature-melted paraffin. The fixed tissue samples were sectioned at 4 µm thickness. The slides were observed under a confocal laser scanning microscope (CLSM, Zeiss 510; Atlanta, GA, USA). Under microscopy the photographs were quantified and analyzed by a computerized system (Image Pro-Plus, Media Cybernetics, MD, USA).
Magnetic resonance image analysis
For effective anatomical magnetic resonance imaging of brain, the mice were weighed and anesthetized. MRI experiments on brain were performed on a 4.7 Tesla MRI/ MRS system with a 35-mm vertical bore size (Varian, Unity Inova, Palo Alto , CA, USA) and a 30-mm Millepede quadrature. T2-weighted MR image was obtained using the following parameters: repetition time (TR)=3,000 ms, echo time (TE)=80 ms, field of view (FOV)=30 × 30 mm, thickness=1 mm, matrix=512 × 512.
Results
Characteristics and analysis of generated FMNPs in nose-only exposure chamber
The TEM study clearly demonstrated that our synthesized FMNPs were monodisperse and showed Fig. 1 . N a n o p a r t i c l e g e n e r a t i o n s y s t e m a n d c h a r a c t e r i z a t i o n o f F M N P s . (A) Schematic diagram of inhalation system for nanoparticle exposure. The nose-only exposure chamber used in our study consists of a cylindrical acrylic cylinder and 20 small tubes. The nanoparticles were generated through an atomizer with the aid of a heating tube to evaporate the remaining water. The generated aerosols were entered into a dilution chamber where they were mixed with air filtered by HEPA cartridge-type filter before passing into the nose-only exposure chamber. Particle number and size distribution were measured using the scanning mobility particle sizer (SMPS). The measurements of particle number and size distribution were performed in total 7 independent analyses with 40 min intervals after achieving stabilization of the nanoparticle generating system. Validation study by SEM of glass fiber captured FMNPs revealed that some FMNPs were aggregated, however, most FMNPs are distributed evenly and uniformly in NOEC during the study. Scale bar: 100 nm. unique size (Fig. 1B) . SMPS study of the particle number of FMNPs in the nose-only exposure chamber demonstrated that there was no significant difference between the two concentration groups [geometric mean diameter (GMD) and geometric standard deviation (GSD) of the FMNPs were 49 nm and 1.8 for the low concentration and 51 nm and 1.7 for the high concentration]. SPMS analysis also demonstrated that the particle number distribution of generated FMNPs was constantly maintained during the exposure period. SMPS analysis revealed that the mice were exposed to FMNPs with total particles number of 4.89 × 10 . SPMS analysis also demonstrated that the particle number distribution of generated FMNPs was constantly maintained during the exposure period (Fig. 1C) . A validation study by SEM of FMNPs, captured on a glass fiber filter, revealed that some FMNPs were aggregated; however, most FMNPs were evenly and uniformly distributed in the nose-only exposure chamber during the study (Fig. 1D) .
Body distribution of Inhaled FMNPs
The body distribution of FMNPs was examined by CLSM and MRI study. As shown in Fig. 2 , FMNPs were distributed in various organs, including the liver, testis, spleen, lung and brain. In contrast, only a few were distributed in the nasal cavity, heart, kidney and ovary. In the liver, the fluorescence intensity of FMNPs was strongest and distributed throughout the whole organ. In the spleen and testis, however, FMNPs were observed in specific regions. Since we were interested in studying brain distribution of FMNPs after inhalation, the brain tissue sections were inspected by MRI. In T2-weighted spin-echo MR images, it could be seen that FMNPs had penetrated the BBB (Fig. 3) 
Discussion
To understand the potential adverse effects of nanomaterials on health, it is important to know the general defense mechanism of living organisms and the interactions between nanoparticles and the immune response. Based on evolutionary history, humans have been exposed to small particles, and have developed defense mechanisms against such particles. Dominant routes of nanomaterial exposure to workers are represented by organs such as the lung (inhalation) and skin (contact) which contain barriers to penetration by small particles. Regardless of the presence of such defense mechanisms, nano-sized materials may present several problems for workers, because their defense mechanisms may not respond properly to nano-sized materials. Mineral quartz, asbestos and particles associated with air pollution are the representative examples of such nanomaterials 3) . There is some limited research related to the impacts of nanomaterials on nonhuman species and about workers affected by nanomaterials. In our previous study, we showed that i.p. administered 50 nm FMNPs could penetrate the blood-brain-barrier without causing significant toxicity 4) . The collection of information on risk assessment via different exposure routes of manufactured nanoparticles is also required. Issues regarding the potential impact of manufactured nanomaterials on human health and environment have been raised only recently 3) . In consideration of these regards, the current inhalation study was performed to determine the distribution pattern of nanomaterials using FMNPs. The SEM study showed that some FMNPs were aggregated (Fig. 1D) . A few aggregations might be caused by Brownian motion and turbulence 8, 9) . Our results indicate that a nanoparticle generating system can be used for an inhalation study of diverse kinds of nanomaterials. In fact, extensive sizedependent inhalation toxicities of various nanomaterials are under investigation. The differences in toxicity depending upon exposure routes (i.p. vs inhalation) are quite interesting. Most likely, first-pass effects by the portal circulation would account for the difference because the majority of i.p. administered FMNPs would be taken up by the liver via the first-pass effect and then be redistributed from the liver to the other organs. However, inhalation exposure route would bypass such liver-related first-pass effect. We studied the organs which are enriched with the reticuloendothelial system (RES) such as the liver, lung and spleen and non-RES organs such as the heart and kidney. Among the RES organs, the spleen was affected by inhalation of FMNPs, thereby, suggesting that the body distribution of the FMNPs in the liver, lung, and spleen might not be associated with the RES system. Our results strongly suggest that other factors may be involved for tissue specific distribution pattern of inhaled FMNPs. The functional mechanism of BBB is thought to be specialized endothelial cells in the brain microvasculature, which are aided at least in part, by interactions with glia. Among the unique properties of these endothelial cells is the presence of . To gain entry to the brain, therefore, the FMNPs would probably have to pass through the cell membrane of the endothelial cells of the brain, rather than between the endothelial cells. The penetration of molecules into the brain is largely related to their lipid solubility and to their ability to pass through the plasma membranes of the cells forming the barrier 11) . However, FMNPs do not show this ability because they are highly water soluble. Moreover, the cells of the brain lack of pinocytosis; therefore, FMNPs would have to gain access to the brain by some other routes. In the mature central nervous system, the spinal and autonomic ganglia as well as a small number of other sites within the brain, called the circumventricular organs, are not protected by the BBB 12) . The discontinuity of the barrier may allow the entry of FMNPs into the brain. Another possibility is that FMNPs may translocate along the olfactory nerve into the olfactory bulb 13) . In fact, a recent report showed that translocation of inhaled nanoparticles along the neurons seemed to be more efficient pathway to the CNS rather than via the BBB 14) . Such efficient translocation of FMNPs via the olfactory neuronal pathway in the nasal cavity (Fig. 2) could be responsible for the observed brain distribution of FMNPs. Moreover, FMNPs also penetrated the testis which is protected by blood-testis barrier (BTB). The production, differentiation, and presence of male gametes represent inimitable challenges to the immune system as the existence of BTB protects the immune privilege of the testis 15) . In this regard, FMNPs may have penetrated BTB, thus, disturbing the maintenance of the immuneprivileged status of the testis. Further study is urgently needed to elucidate the precise mechanism by which FMNPs penetrate BTB and the potential outcome for the distribution of FMNPs in the testis.
We report here that inhaled FMNPs have penetrated the BBB and BTB. Applications of nanotechnologies should not produce adverse effects on human health and the environment. Therefore, to predict and prevent the potential toxicity of nanomaterials, extensive studies should be performed under various exposure routes with different sizes and shapes of nanomaterials.
